Alauna Christian
Psychiatric/Mental Health · Kansas City, MONPI 1801488275
Payments from drug & device makers
Across 52 payments — averaging $55.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$635
- Tris Pharma Inc$449
- E.r. Squibb & Sons, L.L.C.$406
- Otsuka America Pharmaceutical, Inc.$326
- Teva Pharmaceuticals USA, Inc.$260
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$237
- plus $564 from 7 others
What the payments were for
- Food & beverage$2,876100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $635 |
| Tris Pharma Inc | 5 | $449 |
| E.r. Squibb & Sons, L.L.C. | 4 | $406 |
| Otsuka America Pharmaceutical, Inc. | 3 | $326 |
| Teva Pharmaceuticals USA, Inc. | 2 | $260 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $237 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Novo Nordisk | 1 | $112 |
| Vanda Pharmaceuticals Inc. | 1 | $103 |
| Alkermes, Inc. | 1 | $102 |
| Johnson & Johnson | 1 | $96 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$410
- UZEDY$260
- COBENFY$247
- Dyanavel XR$243
- Quillivant$243
- Quillichew ER$243
- VRAYLAR$242
- CAPLYTA$237
- REXULTI$226
- Auvelity$121
- Ozempic$112
- Fanapt$103
How this compares
$2,876 in reported general payments places this provider in the 75th percentile of 565 psychiatric/mental health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 41 | $1,136 |
| Divalproex Sodium | 17 | $714 |
| Mirtazapine | 36 | $496 |
| Duloxetine Hcl | 31 | $366 |
| Gabapentin | 15 | $280 |
| Hydroxyzine Pamoate | 22 | $240 |
| Bupropion XlBupropion Hcl | 15 | $230 |
| Hydroxyzine Hcl | 15 | $199 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $195 |
| Quetiapine Fumarate | 12 | $109 |
| Sertraline Hcl | 41 | $55 |
| Trazodone Hcl | 17 | $23 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $10 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Kansas City
- Cynthia HeckKansas City$9K
- Edward AvilesKansas City$6K
- Redempta BekahKansas City$6K
- Aldijana SacicSaint Louis$510K
- Erin DuvallSpringfield$275K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
- Emily WoukSpringfield$90K
- Kristerpher BrimberryPoplar Bluff$74K
- Matthew LindquistSt Louis$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.